MedTrace Logo

The Effect of Human Adipose Tissue-derived MSCs in Romberg's Disease

NCT01309061 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2019-06-05

No results posted yet for this study

Summary

The purpose of this study is to investigate the efficacy and safety of autologous transplantation of adipose tissue derived mesenchymal stem cells (MSCs) in patient with progressive hemifacial atrophy.

Conditions

  • Progressive Hemifacial Atrophy
  • Romberg's Disease

Interventions

PROCEDURE

Autologous Adipose Tissue derived MSCs Transplantation

Intramuscular infusion of Autologous Adipose Tissue derived MSCs with autologous microlipoinjection. Dose: 1x10e7 cells/500ul/lipoinjection 20ml

Sponsors & Collaborators

  • Asan Medical Center

    collaborator OTHER

  • R-Bio

    lead INDUSTRY

Principal Investigators

  • Jong-Woo Choi, M.D.Ph.D. · Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2009-12-31
Completion
2010-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01309061 on ClinicalTrials.gov